TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM NEW
Total 13F shares
3,206,032
Share change
+2,264,761
Total reported value
$69,914,000
Price per share
$21.82
Number of holders
33
Value change
+$49,413,509
Number of buys
25
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q2 2015

As of 30 Jun 2015, TRILLIUM THERAPEUTICS INC - COM NEW was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,206,032 shares. The largest 10 holders included Private Capital Advisors, Inc., FRANKLIN RESOURCES INC, JANUS CAPITAL MANAGEMENT LLC, EverPoint Asset Management, LLC, Opaleye Management Inc., Point72 Asset Management, L.P., DEERFIELD MANAGEMENT CO, SPHERA FUNDS MANAGEMENT LTD., MILLENNIUM MANAGEMENT LLC, and BOGLE INVESTMENT MANAGEMENT L P /DE/. This page lists 33 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.